Cho-Lea Tso

1.9k total citations
30 papers, 1.5k citations indexed

About

Cho-Lea Tso is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Cho-Lea Tso has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Cho-Lea Tso's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and Prostate Cancer Treatment and Research (7 papers). Cho-Lea Tso is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and Prostate Cancer Treatment and Research (7 papers). Cho-Lea Tso collaborates with scholars based in United States, China and France. Cho-Lea Tso's co-authors include Arie S. Belldegrun, Jean B. deKernion, Linda M. Liau, Timothy F. Cloughesy, Robert A. Figlin, Paul S. Mischel, Randhir Kaboo, Stanley F. Nelson, Zugen Chen and Allan J. Pantuck and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Cho-Lea Tso

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cho-Lea Tso United States	21	776	531	363	361	343	30	1.5k
Hong Xin United States	18	657 0.8×	490 0.9×	487 1.3×	237 0.7×	319 0.9×	33	1.5k
Jana Krošl Canada	24	1.3k 1.7×	435 0.8×	240 0.7×	257 0.7×	430 1.3×	38	2.1k
Bárbara Meléndez Spain	22	859 1.1×	439 0.8×	442 1.2×	241 0.7×	138 0.4×	66	1.6k
Diego M. Marzese United States	25	1.2k 1.5×	507 1.0×	189 0.5×	276 0.8×	203 0.6×	75	1.7k
Yoshimi Arima Japan	27	1.2k 1.5×	906 1.7×	115 0.3×	291 0.8×	239 0.7×	46	2.0k
Rachel A. Altura United States	25	1.3k 1.7×	590 1.1×	158 0.4×	193 0.5×	270 0.8×	48	1.9k
Dirk Kemming Germany	15	683 0.9×	423 0.8×	312 0.9×	159 0.4×	134 0.4×	22	1.3k
Emmanuel Martínez-Ledesma United States	14	1.0k 1.3×	341 0.6×	204 0.6×	314 0.9×	133 0.4×	34	1.6k
Sara Akhavanfard United States	8	801 1.0×	356 0.7×	340 0.9×	248 0.7×	75 0.2×	15	1.4k
Helena Carén Sweden	26	1.4k 1.8×	423 0.8×	537 1.5×	197 0.5×	129 0.4×	76	2.1k

Countries citing papers authored by Cho-Lea Tso

Since Specialization

Citations

This map shows the geographic impact of Cho-Lea Tso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho-Lea Tso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho-Lea Tso more than expected).

Fields of papers citing papers by Cho-Lea Tso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cho-Lea Tso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho-Lea Tso. The network helps show where Cho-Lea Tso may publish in the future.

Co-authorship network of co-authors of Cho-Lea Tso

This figure shows the co-authorship network connecting the top 25 collaborators of Cho-Lea Tso. A scholar is included among the top collaborators of Cho-Lea Tso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cho-Lea Tso. Cho-Lea Tso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamada, Kazunari, Yibei Zhang, William H. McBride, et al.. (2015). Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Molecular Cancer. 14(1). 189–189. 31 indexed citations

Yong, William H., Maryam Shabihkhani, Donatello Telesca, et al.. (2015). Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients. PLoS ONE. 10(10). e0141334–e0141334. 53 indexed citations

Ye, Fei, Yibei Zhang, Yue Liu, et al.. (2013). Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence. PLoS ONE. 8(11). e80397–e80397. 50 indexed citations

Liu, Yue, Fei Ye, Kazunari Yamada, et al.. (2011). Autocrine Endothelin-3/Endothelin Receptor B Signaling Maintains Cellular and Molecular Properties of Glioblastoma Stem Cells. Molecular Cancer Research. 9(12). 1668–1685. 30 indexed citations

Liu, Qinghai, David H. Nguyen, Qinghua Dong, et al.. (2009). Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Journal of Neuro-Oncology. 94(1). 1–19. 100 indexed citations

Tso, Cho-Lea, Peter Shintaku, James Chen, et al.. (2006). Primary Glioblastomas Express Mesenchymal Stem-Like Properties. Molecular Cancer Research. 4(9). 607–619. 184 indexed citations

Tso, Cho-Lea, William A. Freije, Allen Day, et al.. (2006). Distinct Transcription Profiles of Primary and Secondary Glioblastoma Subgroups. Cancer Research. 66(1). 159–167. 152 indexed citations

Pantuck, Allan J., Arndt van Ophoven, Barbara J. Gitlitz, et al.. (2004). Phase I Trial of Antigen-Specific Gene Therapy Using a Recombinant Vaccinia Virus Encoding MUC-1 and IL-2 in MUC-1-Positive Patients With Advanced Prostate Cancer. Journal of Immunotherapy. 27(3). 240–253. 57 indexed citations

Gitlitz, Barbara J., Arie S. Belldegrun, Amnon Zisman, et al.. (2003). A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma. Journal of Immunotherapy. 26(5). 412–419. 73 indexed citations

10.

Hinkel, Andreas, Cho-Lea Tso, Barbara J. Gitlitz, et al.. (2000). Immunomodulatory Dendritic Cells Generated From Nonfractionated Bulk Peripheral Blood Mononuclear Cell Cultures Induce Growth of Cytotoxic T Cells Against Renal Cell Carcinoma. Journal of Immunotherapy. 23(1). 83–93. 16 indexed citations

11.

Mulders, Peter, Cho-Lea Tso, Shen Pang, et al.. (1998). Adenovirus-Mediated Interleukin-2 Production by Tumors Induces Growth of Cytotoxic Tumor-Infiltrating Lymphocytes Against Human Renal Cell Carcinoma. Journal of Immunotherapy. 21(3). 170–180. 8 indexed citations

12.

Sokoloff, Mitchell H., Cho-Lea Tso, Randhir Kaboo, et al.. (1996). In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer. 77(9). 1862–1872. 70 indexed citations

13.

Belldegrun, Arie S., Cho-Lea Tso, Randhir Kaboo, et al.. (1996). Natural Immune Reactivity-Associated Therapeutic Response in Patients with Metastatic Renal Cell Carcinoma Receiving Tumor-Infiltrating Lymphocytes and Interleukin-2-Based Therapy. Journal of Immunotherapy. 19(2). 149–161. 21 indexed citations

14.

Sokoloff, Mitchell H., Cho-Lea Tso, Randhir Kaboo, et al.. (1996). Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging: A Clinicopathological Molecular Analysis of 121 Patients. The Journal of Urology. 156(5). 1560–1566. 79 indexed citations

15.

Sokoloff, Mitchell H., Cho-Lea Tso, Randhir Kaboo, et al.. (1996). Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging. The Journal of Urology. 1560–1566. 1 indexed citations

16.

Pang, Shen, Samir S. Taneja, Pejman Cohan, et al.. (1995). Prostate Tissue Specificity of the Prostate-Specific Antigen Promoter Isolated from a Patient with Prostate Cancer. Human Gene Therapy. 6(11). 1417–1426. 91 indexed citations

17.

Tso, Cho-Lea, Randhir Kaboo, Shen Pang, et al.. (1994). In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer. Cancer. 74(7). 1904–1911. 26 indexed citations

18.

Miller, Alexander R., Kristina Rhoades, Arie S. Belldegrun, et al.. (1992). Simultaneous Use of Two Retroviral Vectors in Human Gene Marking Trials: Feasibility and Potential Applications. Human Gene Therapy. 3(6). 619–624. 17 indexed citations

19.

Koo, Alec S., et al.. (1992). Interleukin-6 and renal cell cancer: Production, regulation, and growth effects. Cancer Immunology Immunotherapy. 35(2). 97–105. 94 indexed citations

20.

Tso, Cho-Lea, et al.. (1992). Modulation of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell Carcinoma by Interleukin-4. Journal of Immunotherapy. 12(2). 82–89. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact